Form 4: Tenaya Therapeutics SVP, Finance Sells Shares to Cover Tax Obligations

Tomohiro Higa, SVP of Finance at Tenaya Therapeutics, sold 1,390 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 16, 2025, Tomohiro Higa, SVP of Finance at Tenaya Therapeutics, sold 1,390 shares of Tenaya Therapeutics, Inc. common stock.
• The shares were sold at a price of $0.4427 per share.
• The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units awarded on August 15, 2024.
• Following the transaction, Higa beneficially owns 98,300 shares, which includes 62,250 shares that will be issued upon vesting of restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine SEC Form 4 filing, indicating a stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

• The sale of shares by an insider could have a minor negative impact on shareholder sentiment, although it is a common practice for covering tax obligations.

Key Dates

Keywords

Tenaya Therapeutics, TNYA, Tomohiro Higa, Form 4, SEC Filing, Stock Sale, Insider Trading, Restricted Stock Units, Tax Withholding